Systemic AA amyloidosis: epidemiology, diagnosis, and management

References

• MerliniGBellottiVMolecular mechanisms of amyloidosisN Engl J Med2003349658359612904524
   PubMed Web of Science ®Google Scholar
• CampistolJMAmiloidosisEnRozmanCCardellachFFarreras/Rozman, Medicina Interna16ª edBarcelonaElsevier España200911471150
   Google Scholar
• PepysMBAmyloidosisAnnu Rev Med20065722324116409147
   PubMed Web of Science ®Google Scholar
• PinneyJHSmithCJTaubeJBSystemic amyloidosis in England: an epidemiological studyBr J Haematol2013161452553223480608
   PubMed Web of Science ®Google Scholar
• ObiciLPerfettiVPalladiniGMorattiRMerliniGClinical aspects of systemic amyloid diseasesBiochim Biophys Acta200517531112216198646
   PubMed Web of Science ®Google Scholar
• Urieli-ShovalSLinkeRPMatznerYExpression and function of serum amyloid A, a major acute-phase protein, in normal and disease statesCurr Opin Hematol200071646910608507
   PubMed Web of Science ®Google Scholar
• ObiciLRaimondiSLavatelliFBellottiVMerliniGSusceptibility to AA amyloidosis in rheumatic diseases: a critical overviewArthritis Rheum200961101435144019790131
   PubMed Web of Science ®Google Scholar
• van der HilstJCRecent insights into the pathogenesis of type AA amyloidosisScientificWorldJournal20111164165021403980
   PubMed Web of Science ®Google Scholar
• NakamuraTHigashiSTomodaKTsukanoMBabaSShonoMSignificance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritisRheumatology (Oxford)2006451434916219644
   PubMed Web of Science ®Google Scholar
• SimmsRWProutMNCohenASThe epidemiology of AL and AA amyloidosisBaillieres Clin Rheumatol1994836276347954866
   PubMed Web of Science ®Google Scholar
• KyleRALinosABeardCMIncidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989Blood1992797181718221558973
   PubMed Web of Science ®Google Scholar
• HemminkiKLiXFörstiASundquistJSundquistKIncidence and survival in non-hereditary amyloidosis in SwedenBMC Public Health20121297423148499
   PubMed Web of Science ®Google Scholar
• Real de AsúaDCostaRContrerasMMGutiérrezÁFiliggheduMTArmasMClinical characteristics of the patients with systemic amyloidosis in 2000–2010Rev Clin Esp2013213418619323246354
   PubMed Web of Science ®Google Scholar
• García MoranJIBarat CascanteAOliva AldámizHAmiloidosis sistémica: Estudio clínico-patológico de 69 casos [Systemic amyloidosis: clinico-pathologic study of 69 cases]Rev Clin Esp19921911811861439037
   PubMedGoogle Scholar
• González-GarcíaJJGarcía-AlegríaJPeñaJMVicandiBPicazoMLFernández-CapitánMCEspectro y correlación clinicopatológica en la amiloidosis renal [Spectrum and clinico-pathological correlations in renal amyloidosis. Study of 44 cases]. Estudio de 44 casosRev Clin Esp19861784214273488566
   PubMed Web of Science ®Google Scholar
• De la SierraACardellachFIngelmoMRosellóRBalcellsAAmiloidosis: aspectos clínicos y biológicos de 60 casos [Amyloidosis: clinical and biological aspects of 60 cases]Med Clin (Barc)1985842973013982152
   PubMed Web of Science ®Google Scholar
• Martínez-VeaATorrasADarnellACarreraMRevertLAmiloidosis primaria y secundaria renal: manifestaciones clínicas, evolución y supervivencia. Estudio comparativo de 37 pacientes [Primary and secondary renal amyloidosis: clinical manifestations, development and survival. Comparative study of 37 patients]Med Clin (Barc)1983801911956855300
   PubMed Web of Science ®Google Scholar
• CastillaJMontesRQueredaCMarcenRRodríguezGPereiraPAmiloidosis renal: estudio clínico en 29 pacientes [Renal amyloidosis: clinical study in 29 patients]Rev Clin Esp1977147349354601292
   PubMed Web of Science ®Google Scholar
• BergesioFCicianiAMSantostefanoMImmunopathology Group, Italian Society of NephrologyRenal involvement in systemic amyloidosis – an Italian retrospective study on epidemiological and clinical data at diagnosisNephrol Dial Transplant20072261608161817395661
   PubMed Web of Science ®Google Scholar
• DixitRGuptaRDaveLPrasadNSharmaSClinical profile of patients having pulmonary tuberculosis and renal amyloidosisLung India2009262414520440393
   PubMedGoogle Scholar
• BarileLArizaRMuciHTru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritisArch Med Res19932421891928274847
   PubMedGoogle Scholar
• KobayashiHTadaSFuchigamiTSecondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsyBr J Rheumatol199635144498624622
   PubMedGoogle Scholar
• TuncaMAkarSOnenFTurkish FMF Study GroupFamilial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter studyMedicine (Baltimore)200584111115643295
   PubMed Web of Science ®Google Scholar
• ImmonenKFinnePGrönhagen-RiskaCA marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases – data from nationwide registries in FinlandAmyloid2011181252821284495
   PubMed Web of Science ®Google Scholar
• JungOHaackHSBuettnerMRenal AA-amyloidosis in intravenous drug users – a role for HIV-infection?BMC Nephrol20121315123171281
   PubMed Web of Science ®Google Scholar
• LachmannHJGoodmanHJGilbertsonJANatural history and outcome in systemic AA amyloidosisN Engl J Med2007356232361237117554117
   PubMed Web of Science ®Google Scholar
• GertzMAComenzoRFalkRHDefinition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, April 18–22, 2004Am J Hematol200579431932816044444
   PubMed Web of Science ®Google Scholar
• WestermarkPStenkvistBA new method for the diagnosis of systemic amyloidosisArch Intern Med197313245225234742405
   PubMedGoogle Scholar
• van GamerenIIHazenbergBPBijzetJVan RijswijkMHDiagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practiceArthritis Rheum20065462015202116732553
   PubMed Web of Science ®Google Scholar
• HachullaEGrateauGDiagnostic tools for amyloidosisJoint Bone Spine200269653854512537260
   PubMed Web of Science ®Google Scholar
• CaporaliRBonacciEEpisOBobbio-PallaviciniFMorbiniPMontecuccoCSafety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single centerArthritis Rheum200859571472018438907
   PubMed Web of Science ®Google Scholar
• HowieAJBrewerDBOptical properties of amyloid stained by Congo red: history and mechanismsMicron200940328530119019688
   PubMed Web of Science ®Google Scholar
• CooperJHAn evaluation of current methods for the diagnostic histochemistry of amyloidJ Clin Pathol19692244104135798627
   PubMed Web of Science ®Google Scholar
• HowieAJOwen-CaseyMPDiscrepancies between descriptions and illustrations of colours in Congo red-stained amyloid, and explanation of discrepant coloursAmyloid2010173–410911721039325
   PubMed Web of Science ®Google Scholar
• LinkeRPOn typing amyloidosis using immunohistochemistry. Detailled illustrations, review and a note on mass spectrometryProg Histochem Cytochem20124726113222819384
   PubMedGoogle Scholar
• IshiiWMatsudaMNakamuraNPhenol Congo red staining enhances the diagnostic value of abdominal fat aspiration biopsy in reactive AA amyloidosis secondary to rheumatoid arthritisIntern Med200342540040512793709
   PubMed Web of Science ®Google Scholar
• GiorgadzeTAShiinaNBalochZWTomaszewskiJEGuptaPKImproved detection of amyloid in fat pad aspiration: an evaluation of Congo red stain by fluorescent microscopyDiagn Cytopathol200431530030615468138
   PubMed Web of Science ®Google Scholar
• DevataSHariPMarkelovaNLiRKomorowskiRShidhamVBDetection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sectionsCytojournal201181121760829
   PubMed Web of Science ®Google Scholar
• LachmannHJBoothDRBoothSEMisdiagnosis of hereditary amyloidosis as AL (primary) amyloidosisN Engl J Med2002346231786179112050338
   PubMed Web of Science ®Google Scholar
• KebbelARöckenCImmunohistochemical classification of amyloid in surgical pathology revisitedAm J Surg Pathol200630667368316723844
   PubMed Web of Science ®Google Scholar
• VranaJAGamezJDMaddenBJTheisJDBergenHRDoganAClassification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimensBlood2009114244957495919797517
   PubMed Web of Science ®Google Scholar
• HazenbergBPvan RijswijkMHPiersDADiagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosisAm J Med20061194355.e15355.e2416564782
   PubMed Web of Science ®Google Scholar
• LachmannHJGilbertsonJAGillmoreJDHawkinsPNPepysMBUnicentric Castleman’s disease complicated by systemic AA amyloidosis: a curable diseaseQJM200295421121811937647
   PubMed Web of Science ®Google Scholar
• CastellanoIGómez-MartinoJRHernándezMTNovilloRCovarsíARemission of nephrotic syndrome caused by renal amyloidosis secondary to pulmonary tuberculosis after tuberculostatic treatmentNefrologia20012118891 Spanish11344968
   PubMed Web of Science ®Google Scholar
• CerquagliaCDiacoMNuceraGLa ReginaMMontaltoMMannaRPharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an updateCurr Drug Targets Inflamm Allergy20054111712415720245
   PubMedGoogle Scholar
• MeinzerUQuartierPAlexandraJFHentgenVRetornazFKoné-PautIInterleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literatureSemin Arthritis Rheum201141226527121277619
   PubMed Web of Science ®Google Scholar
• Ter HaarNLachmannHÖzenSPaediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever/Eurotraps ProjectsTreatment of autoinflammatory diseases: results from the Eurofever Registry and a literature reviewAnn Rheum Dis201372567868522753383
   PubMed Web of Science ®Google Scholar
• ChevrelGJenvrinCMcGregorBMiossecPRenal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamideRheumatology (Oxford)200140782182511477289
   PubMed Web of Science ®Google Scholar
• Fernández-NebroATomeroEOrtiz-SantamaríaVTreatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonistsAm J Med2005118555255615866260
   PubMed Web of Science ®Google Scholar
• InoueDArimaHKawanamiCExcellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritisClin Rheumatol201029101195119720229259
   PubMed Web of Science ®Google Scholar
• Magro-ChecaCNavas-Parejo CasadoASuccessful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosisAmyloid201118423523921992511
   PubMed Web of Science ®Google Scholar
• Redondo-PachónMDEnríquezRSirventAETocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet’s diseaseRen Fail201335454755023472940
   PubMed Web of Science ®Google Scholar
• AmemoriSIwakiriREndoHOral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart reviewJ Gastroenterol200641544444916799886
   PubMed Web of Science ®Google Scholar
• DemberLMHawkinsPNHazenbergBPEprodisate for AA Amyloidosis Trial GroupEprodisate for the treatment of renal disease in AA amyloidosisN Engl J Med2007356232349236017554116
   PubMed Web of Science ®Google Scholar
• CT Development America, IncEfficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis Available from: http://clinicaltrials.gov/ct2/show/NCT01215747?term=eprodisate&rank=1. NLM identifier: NCT01215747Accessed August 19, 2014
   Google Scholar
• ZhuHYuJKindyMSInhibition of amyloidosis using low-molecular-weight heparinsMol Med20017851752211591887
   PubMed Web of Science ®Google Scholar
• van der HilstJCKluve-BeckermanBBodarEJvan der MeerJWDrenthJPSimonALovastatin inhibits formation of AA amyloidJ Leukoc Biol20088351295129918285405
   PubMed Web of Science ®Google Scholar
• FushimiTTakahashiYKashimaYSevere protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotideAmyloid2005121485316076611
   PubMed Web of Science ®Google Scholar
• OzdemirBHOzdemirFNSezerSSarAHaberalMAmong therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosisTransplant Proc200638243243416549140
   PubMed Web of Science ®Google Scholar
• GillmoreJDTennentGAHutchinsonWLSustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisBr J Haematol2010148576076720064157
   PubMed Web of Science ®Google Scholar
• Kluve-BeckermanBHardwickJDuLAntisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosisAmyloid201118313614621830877
   PubMed Web of Science ®Google Scholar
• KennelSJMacySWooliverCPhagocyte depletion inhibits AA amyloid accumulation in AEF-induced huIL-6 transgenic miceAmyloid2014211455324446872
   PubMed Web of Science ®Google Scholar